Total Payments
$5,748
2024 Payments
$1,179
Companies
23
Transactions
259
Medicare Patients
323
Medicare Billing
$38,867
Payment Breakdown by Category
Food & Beverage$5,744 (99.9%)
Education$4.50 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,744 | 258 | 99.9% |
| Education | $4.50 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,182 | 51 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $860.20 | 41 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $802.85 | 41 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $630.07 | 19 | $0 (2020) |
| ABBVIE INC. | $455.88 | 25 | $0 (2024) |
| Lilly USA, LLC | $381.62 | 17 | $0 (2024) |
| Novo Nordisk Inc | $330.43 | 16 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $160.65 | 7 | $0 (2019) |
| SK Life Science, Inc. | $124.99 | 1 | $0 (2022) |
| Exact Sciences Corporation | $123.05 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,179 | 58 | AstraZeneca Pharmaceuticals LP ($244.89) |
| 2023 | $903.06 | 45 | Boehringer Ingelheim Pharmaceuticals, Inc. ($182.18) |
| 2022 | $1,292 | 49 | Amgen Inc. ($535.25) |
| 2021 | $957.07 | 49 | Amgen Inc. ($247.58) |
| 2020 | $607.38 | 30 | Amgen Inc. ($164.06) |
| 2019 | $275.93 | 10 | SANOFI-AVENTIS U.S. LLC ($233.98) |
| 2018 | $372.44 | 10 | SANOFI-AVENTIS U.S. LLC ($329.46) |
| 2017 | $161.92 | 8 | Regeneron Healthcare Solutions, Inc. ($95.89) |
All Payment Transactions
259 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: DIABETES | ||||||
| 12/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Inflammation | ||||||
| 11/22/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $9.60 | General |
| Category: Inflammation | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: RESPIRATORY | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: DIABETES | ||||||
| 10/02/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Inflammation | ||||||
| 09/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: DIABETES | ||||||
| 09/18/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $29.72 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: Biological | ||||||
| 09/11/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Endocrinology | ||||||
| 09/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $10.46 | General |
| Category: Inflammation | ||||||
| 09/10/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: Inflammation | ||||||
| 08/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Diabetes | ||||||
| 08/27/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: RESPIRATORY | ||||||
| 08/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: DIABETES | ||||||
| 08/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Respiratory | ||||||
| 08/06/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $26.30 | General |
| Category: Endocrinology | ||||||
| 08/02/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Diabetes | ||||||
| 07/20/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Oncology | ||||||
| 07/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $9.09 | General |
| Category: Inflammation | ||||||
| 07/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $26.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 81 | 169 | $15,375 | $8,863 |
| 2022 | 4 | 80 | 175 | $17,145 | $9,923 |
| 2021 | 4 | 80 | 142 | $15,300 | $9,313 |
| 2020 | 4 | 82 | 191 | $21,050 | $10,769 |
Total Patients
323
Total Services
677
Medicare Billing
$38,867
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 19 | 45 | $6,975 | $4,740 | 68.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 41 | $5,125 | $2,977 | 58.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 16 | $1,600 | $583.75 | 36.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 28 | 67 | $1,675 | $562.80 | 33.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 62 | $7,750 | $4,723 | 60.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 20 | 39 | $6,045 | $4,146 | 68.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 20 | $2,000 | $893.74 | 44.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 28 | 54 | $1,350 | $160.08 | 11.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 27 | 45 | $6,975 | $4,733 | 67.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 21 | 56 | $7,000 | $4,356 | 62.2% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 12 | 12 | $600.00 | $136.82 | 22.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 20 | 29 | $725.00 | $87.00 | 12.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 26 | 88 | $11,000 | $5,362 | 48.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 24 | 55 | $8,525 | $5,129 | 60.2% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 13 | 13 | $650.00 | $173.90 | 26.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 19 | 35 | $875.00 | $104.58 | 12.0% |
About Dr. Kamilla Ismailoff, MD
Dr. Kamilla Ismailoff, MD is a Hospitalist healthcare provider based in South Richmond Hill, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/21/2009. The National Provider Identifier (NPI) number assigned to this provider is 1992034961.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kamilla Ismailoff, MD has received a total of $5,748 in payments from pharmaceutical and medical device companies, with $1,179 received in 2024. These payments were reported across 259 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($5,744).
As a Medicare-enrolled provider, Ismailoff has provided services to 323 Medicare beneficiaries, totaling 677 services with total Medicare billing of $38,867. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Hospitalist
- Other Specialties Internal Medicine
- Location South Richmond Hill, NY
- Active Since 12/21/2009
- Last Updated 03/17/2018
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1992034961
Products in Payments
- Repatha (Biological) $749.98
- JARDIANCE (Drug) $661.87
- PRALUENT (Drug) $584.54
- FARXIGA (Drug) $550.04
- Otezla (Drug) $432.47
- BREZTRI (Drug) $223.89
- Ozempic (Drug) $213.22
- QULIPTA (Drug) $209.46
- MOUNJARO (Drug) $166.62
- UBRELVY (Drug) $148.27
- SYNJARDY (Drug) $134.70
- XCOPRI (Drug) $124.99
- Cologuard Collection Kit (Device) $123.05
- PRALUENT ALIROCUMAB INJECTION (Biological) $118.70
- Rybelsus (Drug) $117.21
- TRULICITY (Drug) $102.28
- TRADJENTA (Drug) $99.05
- VRAYLAR (Drug) $87.68
- AIRSUPRA (Drug) $86.27
- PENNSAID (Drug) $77.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.